Keyphrases
Confidence Interval
100%
Lumbar Scoliosis
75%
United States
64%
Cancer Risk
52%
Cancer Incidence
43%
Non-Hodgkin Lymphoma
42%
Adjusted Hazard Ratio
37%
Risk Factors
34%
Antiretroviral Therapy
32%
Rotator Cuff Tear
30%
Patient-Reported Outcomes Measurement Information System (PROMIS)
28%
Hazard Ratio
28%
Transplant Recipients
26%
HIV Patients
26%
Nonoperative
25%
UK Biobank
25%
Oswestry Disability Index
22%
SRS-22
21%
Incidence Rate
20%
AIDS/HIV
20%
Standardized Incidence Ratio
19%
Solid Organ Transplant Recipients
19%
Operative versus Nonoperative Treatment
19%
Multicenter Cohort Study
18%
Kidney Transplant Recipients
18%
Genetic Risk
18%
5-year Follow-up
18%
Sirolimus
18%
Combined Antiretroviral Therapy (cART)
18%
Lung Transplantation
18%
Operative
17%
Cancer Registry
17%
Operative Treatment
17%
CD4 Count
16%
Lymphoma
15%
Antiretroviral Therapy Initiation
15%
People Living with HIV (PLHIV)
15%
Surveillance Epidemiology
15%
Disability
15%
Osteoarthritis
15%
Transplantation
15%
AIDS-defining Illness
15%
Immunosuppression
15%
Non-associated
14%
Nonoperative Treatment
14%
Squamous Cell Carcinoma (SqCC)
13%
HIV RNA
13%
Genetic Markers
12%
Melanoma Risk
12%
Transplant Registry
12%
Medicine and Dentistry
Human Immunodeficiency Virus
74%
Scoliosis
73%
Malignant Neoplasm
71%
Transplantation
51%
Antiretroviral Therapy
49%
Cancer Risk
42%
Hazard Ratio
40%
Non-Hodgkin Lymphoma
39%
Cancer Incidence
38%
Patient-Reported Outcome
34%
Rotator Cuff Injury
30%
Surgery
28%
Conservative Treatment
27%
Medicare
20%
Melanoma
18%
Oswestry Disability Index
17%
Cancer Registry
16%
Squamous Cell Carcinoma
16%
Immunosuppressive Treatment
16%
Prevalence
15%
Cohort Analysis
14%
Pelvis
14%
Human Immunodeficiency Virus Infection
14%
Population
14%
Kidney Graft
13%
Health Care Cost
13%
Acetabular
13%
UK Biobank
13%
Sacrum
13%
Adverse Event
13%
Standardized Incidence Ratio
13%
Outcome Assessment
12%
Cost-Effectiveness Analysis
12%
Leukoplakia
12%
Orthopedics
12%
Oral Cancer
12%
Pediatrics
12%
Rapamycin
12%
Keratinocyte
12%
Immune Response
12%
Genetic Marker
12%
Surveillance, Epidemiology, and End Results
11%
Dysplasia
11%
Logistic Regression Analysis
11%
Odds Ratio
10%
Kaposi Sarcoma
10%
Cancer Diagnosis
10%
Body Mass Index
10%
Proportional Hazards Model
9%
Intention-to-Treat Analysis
9%